Company intelligence / Profile preview
Merken Biotech
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
Overview
Merken Biotech specializes in contract discovery and R&D services with expertise spanning molecular biology, cell biology, microbiology, pharmacology, histology & immunochemistry, immunology, and bioprocess engineering. Their internal research focuses on small molecule modulators of the UPR/ISR pathways for potential use against age-related cognitive decline. They have demonstrated reversal of spatial memory deficits in aged mice via pharmacological modulation of ISR.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculeAntibodyNucleic acid (e.g., oligonucleotide)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Merken Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Merken Biotech.